What is KeyCorp’s Estimate for RPID FY2024 Earnings?

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) – Equities research analysts at KeyCorp issued their FY2024 earnings estimates for Rapid Micro Biosystems in a research note issued to investors on Tuesday, February 11th. KeyCorp analyst P. Knight expects that the company will post earnings of ($1.10) per share for the year. KeyCorp currently has a “Strong-Buy” rating on the stock. The consensus estimate for Rapid Micro Biosystems’ current full-year earnings is ($1.09) per share. KeyCorp also issued estimates for Rapid Micro Biosystems’ Q1 2025 earnings at ($0.27) EPS, Q2 2025 earnings at ($0.25) EPS, Q3 2025 earnings at ($0.24) EPS, Q4 2025 earnings at ($0.23) EPS, FY2025 earnings at ($0.97) EPS and FY2026 earnings at ($0.82) EPS.

Rapid Micro Biosystems Price Performance

RPID stock opened at $3.57 on Friday. Rapid Micro Biosystems has a 52 week low of $0.58 and a 52 week high of $3.75. The company’s 50-day moving average price is $1.45 and its 200 day moving average price is $1.11.

Institutional Trading of Rapid Micro Biosystems

An institutional investor recently raised its position in Rapid Micro Biosystems stock. Renaissance Technologies LLC raised its holdings in Rapid Micro Biosystems, Inc. (NASDAQ:RPID) by 122.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 183,087 shares of the company’s stock after purchasing an additional 100,942 shares during the period. Renaissance Technologies LLC owned 0.43% of Rapid Micro Biosystems worth $165,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 52.60% of the company’s stock.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.